FIELD: biotechnology.
SUBSTANCE: the invention relates to producing new peptides and may be used for treatment and prophylaxis of cytokine-sensitive disorders. Peptides, having a size of 5 to 40 amino acids and arising from cytokines, are used in a vaccine for treatment and prophylaxis of autoimmune diseases, disseminated sclerosis, rheumatoid polyarthritis, psoriasis, autoimmune diabeteses, lupus, allergy, asthma, cancer and AIDS.
EFFECT: allows effective immunization of patients against said diseases while minimizing side effects.
11 cl, 2 dwg, 17 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCES AND METHODS FOR USE IN THE PREVENTION AND/OR TREATMENT OF HUNTINGTON'S DISEASE | 2015 |
|
RU2742493C2 |
| PCSK9 VACCINES | 2015 |
|
RU2698971C2 |
| VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
| VACCINE COMPOSITION AND USE THEREOF | 2016 |
|
RU2726411C2 |
| IMMUNOGEN PEPTIDE AGAINST GROUP A STREPTOCOCCI | 2018 |
|
RU2775621C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2013 |
|
RU2696566C2 |
| IMMUNOREGULATORY VACCINE | 2013 |
|
RU2650709C2 |
| IMMUNOGENIC COMPOSITION, VACCINE COMPRISING SAME, KIT FOR PREPARING SAID COMPOSITION AND METHOD OF TREATING DISEASES ASSOCIATED WITH GASTRIN SECRETION PATHOLOGY | 2014 |
|
RU2664197C2 |
| SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER | 1993 |
|
RU2141527C1 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
